Sc. Thornton et al., BOTH IN-VITRO AND IN-VIVO IRRADIATION ARE ASSOCIATED WITH INDUCTION OF MACROPHAGE-DERIVED FIBROBLAST GROWTH-FACTORS, Clinical and experimental immunology, 103(1), 1996, pp. 67-73
Fibrosis in the lung directly underlying the field of irradiation is a
n almost universal long term sequelae of thoracic irradiation. It is a
ssumed to represent the consequence of direct damage to local tissues
and/or vascular endothelium by ionizing radiation. This view, however,
is not in keeping with our current understanding of fibrotic processe
s, which suggest that growth factors for fibroblasts (including platel
et-derived growth factor (PDGF), insulin-like growth factor I (IGF-I))
and cytokines stimulating collagen synthesis (notably transforming gr
owth factor-beta) are largely responsible for this process. Since a ma
jor source of these factors is the macrophage, present in large number
s within the lung, it appeared possible that radiation-induced fibrosi
s might be mediated by similar mechanisms. Therefore, a study was desi
gned to determine, first, whether in vitro irradiation of mononuclear
phagocytes could induce the release of growth factors for fibroblasts.
Second, we wished to ascertain whether these same growth factors migh
t also be secreted by bronchoalveolar cells from humans who had underg
one in vivo thoracic irradiation. The results of this study indicate t
hat irradiation of a number of different types of mononuclear phagocyt
es resulted in the dose-dependent synthesis and release of several gro
wth factors for fibroblasts, including PDGF, tumour necrosis factor-al
pha (TNF-alpha) and IGF-I. Further, cells obtained by bronchoalveolar
lavage from patients undergoing thoracic radiation spontaneously relea
sed PDGF following irradiation. These findings strongly support the co
ntention that synthesis and release of macrophage-derived growth facto
rs for fibroblasts (particularly PDGF and IGF-I) occur after thoracic
irradiation and play a significant role in the pathogenesis of irradia
tion-induced pulmonary fibrosis in humans.